Introduction
Amoxycillin and clavulanic acid is a potent antimicrobial combination extensively used in bacterial infection management. CLAVAMOXY DS ORAL SUSPENSION contains the chemical composition of Amoxycillin 400mg and Clavulanic Acid 57mg, a formulation designed to enhance antibacterial efficacy by combining a β-lactam antibiotic with a β-lactamase inhibitor.
Mechanism of Action
Amoxycillin, a β-lactam antibiotic, exerts bactericidal action by inhibiting the synthesis of bacterial cell wall mucopeptides, leading to cell lysis. However, many bacteria produce β-lactamase enzymes that inactivate amoxycillin, rendering it ineffective. Clavulanic acid, structurally related to penicillins, inhibits these β-lactamase enzymes irreversibly, protecting amoxycillin from enzymatic destruction. This dual action allows the combination to overcome β-lactamase producing bacterial resistance and broaden the antibacterial spectrum to include resistant strains. This synergistic effect makes amoxycillin and clavulanic acid effective in treating a wide range of infections
Uses and Indications
CLAVAMOXY DS ORAL SUSPENSION is indicated for bacterial infections including respiratory tract infections (such as bronchitis and pneumonia), ear infections (acute otitis media), urinary tract infections, skin and soft tissue infections, and other infections caused by β-lactamase producing bacteria. It is especially suitable for infections caused by pathogens resistant to amoxycillin alone due to β-lactamase production
Efficacy and Clinical Evidence
Clinical studies have demonstrated that the combination of amoxycillin and clavulanic acid effectively treats both susceptible and resistant bacterial infections. The formulation results in adequate blood, tissue, and fluid concentrations necessary for therapeutic effect. The clavulanic acid component ensures sustained amoxycillin activity against β-lactamase-producing pathogens, thereby improving clinical outcomes in resistant infections
Side Effects and Safety Profile
Common side effects include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Allergic reactions such as rash, urticaria, and in rare cases, anaphylaxis may occur. Liver enzyme elevations and jaundice have been reported, particularly in prolonged use or in patients with pre-existing liver conditions. Overall, CLAVAMOXY DS is considered safe when used as directed, but monitoring is advised in sensitive populations.
Contraindications and Precautions
CLAVAMOXY DS ORAL SUSPENSION should not be used in patients with a known allergy to amoxycillin, clavulanic acid, penicillins, or cephalosporin antibiotics. Caution is advised in patients with hepatic impairment or a history of liver disease. Use during pregnancy and breastfeeding should be under medical supervision. Proper dosage and duration are essential to minimize resistance development and adverse effects.
Drug Interactions
Co-administration with probenecid can delay the renal excretion of amoxycillin but does not significantly alter clavulanic acid elimination. Concurrent use with other nephrotoxic drugs or anticoagulants requires careful monitoring due to potential additive effects or interference.
Warnings and Regulatory Status
CLAVAMOXY DS is regulated as a prescription medication. It should be administered under medical guidance to avoid misuse leading to resistance. Patients with liver dysfunction, severe allergies, or hypersensitivity to β-lactam antibiotics should avoid this medicine. Regular monitoring of liver function tests may be necessary during extended therapy
Patient Advice and Tips
Take the suspension exactly as prescribed, completing the full course even if symptoms improve.
Store the reconstituted suspension as advised, usually refrigerated, and discard after the expiry date.
Inform the healthcare provider about any history of allergies, liver disease, or other medications.
Report any severe allergic reactions promptly.
Maintain adequate hydration during therapy.
Availability
CLAVAMOXY DS ORAL SUSPENSION, containing amoxycillin 400mg and clavulanic acid 57mg, is available in pharmacies as a liquid oral suspension. It is marketed by various pharmaceutical companies, including Steris Healthcare Pvt Ltd.
Frequently Asked Questions
What is amoxycillin and clavulanic acid used for?
It is used to treat a variety of bacterial infections, particularly those caused by bacteria resistant to amoxycillin alone due to β-lactamase enzyme production.Why choose Steris Healthcare Pvt Ltd?
Steris Healthcare Pvt Ltd ensures high-quality manufacturing standards, reliable supply, and adherence to regulatory guidelines, providing effective and safe medication to patients.Can Clavamoxy be used in children?
Yes, Clavamoxy DS Oral Suspension is often prescribed for pediatric bacterial infections, dosed according to weight and severity of infection.Are there any special storage requirements?
Yes, the suspension should be stored refrigerated after reconstitution and used within the recommended timeframe to maintain efficacy.What should I do if I miss a dose?
Take the missed dose as soon as you remember unless it is near the time for the next dose. Do not double the dose to catch up.
Conclusion
CLAVAMOXY DS ORAL SUSPENSION, with its effective combination of amoxycillin and clavulanic acid, offers a broad-spectrum antibiotic therapy that combats resistant bacterial infections effectively. Its synergistic mechanism, safety profile, and proven clinical efficacy make it an essential choice in antimicrobial treatment, provided it is used judiciously under medical supervision.
